In a groundbreaking study, researchers have found that a quick MRI scan can detect twice as many serious prostate cancer cases compared to the traditional PSA blood test. This simple ten-minute scan has proven to be far more effective in identifying prostate cancer cases, leading to improved accuracy in diagnosis.
Under current guidelines, men with a PSA reading below 3 nanograms per milliliter are considered low risk for prostate cancer and are not referred for further investigations. However, the study discovered that more than half of the men in the trial who had an abnormality detected through an MRI scan and were subsequently diagnosed with prostate cancer had a PSA level below 3.
Moreover, this study introduced a new measure called PSA “density” which takes into account the PSA level from a blood test in relation to the volume of the prostate gland. This measure proved to be more accurate as PSA levels and prostate size tend to increase with age.
Terry Noonan, a participant in the trial, discovered he had an aggressive prostate cancer through the MRI scan. He underwent a prostate removal surgery within weeks and is now cancer-free. Reflecting on his experience, Mr. Noonan expressed gratitude for being part of the trial and considered himself fortunate for the successful treatment he received.
Experts believe that this new approach, combining the ten-minute MRI scan with PSA density, could revolutionize prostate cancer diagnosis and potentially lead to a national screening program for the disease. Caroline Moore, a Professor of Urology at University College London, who led the research, emphasized the need for a fresh perspective on screening methods, given that over half of the men with clinically significant cancer in the study had a PSA level below 3ng/ml.
Currently, over 52,000 men are diagnosed with prostate cancer in the UK each year, with more than 12,000 deaths attributed to the disease. Despite its unreliable nature, the standard PSA test remains the most common method for determining the need for further testing. This results in unnecessary tests for some and delays in diagnosing cancer for others.
The study involved 303 men aged 50 to 75 who underwent a ten-minute MRI scan of the prostate and a PSA density test. The MRI scan identified that 16% of the participants, or 48 men, were at risk of cancer. Surprisingly, two-thirds of these men had a PSA level under 3. Further analysis revealed that 25 of these men required treatment for prostate cancer, and 15 of them would not have been detected through the standard PSA test.
Additionally, the PSA density test identified an additional 16 men at risk of prostate cancer, four of whom had the disease that required treatment. These findings illustrate the potential of quick MRI scans in detecting serious prostate cancer cases early and potentially saving lives.
In conclusion, the introduction of quick MRI scans and the use of PSA density as a screening measure could revolutionize prostate cancer diagnosis. This innovation has the potential to prevent unnecessary tests and ensure that men with prostate cancer receive timely treatment. With further research and implementation, this approach could pave the way for a nationwide screening program for prostate cancer.
Denial of responsibility! VigourTimes is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
